Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) FCF Margin (2016 - 2025)

Historic FCF Margin for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to 4.24%.

  • Sanara MedTech's FCF Margin fell 51800.0% to 4.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.83%, marking a year-over-year increase of 17300.0%. This contributed to the annual value of 0.26% for FY2024, which is 51400.0% up from last year.
  • Latest data reveals that Sanara MedTech reported FCF Margin of 4.24% as of Q3 2025, which was down 51800.0% from 3.49% recorded in Q2 2025.
  • Sanara MedTech's FCF Margin's 5-year high stood at 9.42% during Q3 2024, with a 5-year trough of 27.62% in Q1 2022.
  • In the last 5 years, Sanara MedTech's FCF Margin had a median value of 8.96% in 2024 and averaged 9.15%.
  • Its FCF Margin has fluctuated over the past 5 years, first plummeted by -81900bps in 2021, then soared by 228200bps in 2022.
  • Quarter analysis of 5 years shows Sanara MedTech's FCF Margin stood at 27.38% in 2021, then surged by 83bps to 4.56% in 2022, then fell by -12bps to 5.1% in 2023, then surged by 164bps to 3.27% in 2024, then rose by 30bps to 4.24% in 2025.
  • Its FCF Margin was 4.24% in Q3 2025, compared to 3.49% in Q2 2025 and 15.88% in Q1 2025.